Contact Us

Pharmaceutical Translation: When 0.01% Accuracy Difference Becomes a Patient Safety Issue

Pharmaceutical translation mistakes—even minor decimal or instruction errors—can endanger patients, delay clinical trials, and cause financial penalties. This article highlights the deadliest translation errors: numerical mistakes, contraindication misinterpretation, and ambiguous medical device instructions. WordPar mitigates risks with regulatory-grade terminology, two-person clinical review, numerical verification, and audit-ready documentation, ensuring compliance and patient safety across global markets.

The Death of “Price Per Word”: Why Outcome-Based Localization is the Future

The traditional price-per-word model is failing as AI-powered translation reshapes localization. Outcome-based localization ties pricing to measurable business impact, including subscription, revenue-sharing, performance-based, or flat-fee models. For global businesses in legal, pharma, e-learning, and tech sectors, this approach ensures predictable budgets, quality-focused results, and risk mitigation. WordPar leads the shift by integrating AI, human expertise, and flexible pricing to deliver outcomes, not just translated words.

7 Localization Myths That Are Costing You Money (And the Truth That Saves It)

Many businesses assume that translation alone is enough for international success—but effective localization goes far beyond converting words from one language to another. Misconceptions such as relying solely on machine translation, delaying localization until after development, or choosing the cheapest vendor can lead to costly mistakes, damaged brand reputation, and missed global opportunities.